Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation. [electronic resource]
Producer: 20171121Description: 233-239 p. digitalISSN:- 1879-0852
- Adolescent
- Adult
- Aged
- Antineoplastic Agents -- adverse effects
- Biomarkers, Tumor -- genetics
- Disease Progression
- Disease-Free Survival
- Female
- Germany
- Humans
- Kaplan-Meier Estimate
- Leukemia, Myeloid, Acute -- enzymology
- Male
- Middle Aged
- Niacinamide -- adverse effects
- Phenylurea Compounds -- adverse effects
- Protein Kinase Inhibitors -- adverse effects
- Recurrence
- Remission Induction
- Retrospective Studies
- Risk Factors
- Sorafenib
- Stem Cell Transplantation -- adverse effects
- Tandem Repeat Sequences
- Time Factors
- Transplantation, Homologous
- Treatment Outcome
- Young Adult
- fms-Like Tyrosine Kinase 3 -- genetics
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.